- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Business Development Office
- Partnering opportunities
- A complete cure for HBV
- A stable efficacious Toxoplasma vaccine
- Activating SMCHD1 to treat FSHD
- Improving vision outcomes in retinal detachment
- Intercepting inflammation with RIPK2 inhibitors
- Novel inhibitors for the treatment of lupus
- Novel malaria vaccine
- Novel mucolytics for the treatment of respiratory diseases
- Precision epigenetics silencing SMCHD1 to treat Prader Willi Syndrome
- Rethinking CD52 a therapy for autoimmune disease
- Targeting minor class splicing
- Partnerships and collaborations
- Royalties distribution
- Start-up companies
- Collaborators
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- People
- Anne-Laure Puaux
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Alyssa Barry
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Daniel Gray
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Emma Josefsson
- Associate Professor Ethan Goddard-Borger
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Murphy
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeanne Tie
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Leanne Robinson
- Associate Professor Marco Herold Marco Herold
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Matthew Ritchie
- Associate Professor Melissa Davis
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Peter Czabotar
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Sandra Nicholson
- Associate Professor Sant-Rayn Pasricha
- Associate Professor Seth Masters
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Wai-Hong Tham
- Associate Professor Wei Shi
- Catherine Parker
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gemma Kelly
- Dr Gwo Yaw Ho
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Joanna Groom
- Dr John Wentworth
- Dr Kelly Rogers
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Melissa Call
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Samir Taoudi
- Dr Shalin Naik
- Dr Sheau Wen Lok
- Dr Simon Chatfield
- Dr Tracy Putoczki
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Joel Chibert
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Lew
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Gabrielle Belz
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor Jane Visvader
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marc Pellegrini
- Professor Marnie Blewitt
- Professor Melanie Bahlo
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Burgess
- Professor Tony Papenfuss
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Undergraduate
- Student research projects
- A new regulator of stemness to create dendritic cell factories for immunotherapy
- Advanced methods for genomic rearrangement detection
- Control of cytokine signaling by SOCS1
- Defining the protein modifications associated with respiratory disease
- Delineating the pathways driving cancer development and therapy resistance
- Developing a new drug that targets plasmacytoid dendritic cells for the treatment of lupus
- Development and mechanism of action of novel antimalarials
- Development of a novel particle-based malaria vaccine
- Development of tau-specific therapeutic and diagnostic antibodies
- Discovering novel therapies for major human pathogens
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Epigenetic biomarkers of tuberculosis infection
- Essential role of glycobiology in malaria parasites
- Evolution of haematopoiesis in vertebrates
- Human lung protective immunity to tuberculosis
- Identifying novel treatment options for ovarian carcinosarcoma
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigating the role of mutant p53 in cancer
- Microbiome strain-level analysis using long read sequencing
- Minimising rheumatic adverse events of checkpoint inhibitor cancer therapy
- Modelling spatial and demographic heterogeneity of malaria transmission risk
- Naturally acquired immune response to malaria parasites
- Predicting the effect of non-coding structural variants in cancer
- Structural basis of catenin-independent Wnt signalling
- Structure and biology of proteins essential for Toxoplasma parasite invasion
- T lymphocytes: how memories are made
- TICKER: A cell history recorder for longitudinal patient monitoring
- Targeting host pathways to develop new broad-spectrum antiviral drugs
- Targeting post-translational modifications to disrupting the function of secreted proteins
- Targeting the epigenome to rewire pro-allergic T cells
- Targeting the immune microenvironment to treat KRAS-mutant adenocarcinoma
- The E3 ubiquitin ligase Parkin and mitophagy in Parkinson’s disease
- The molecular controls on dendritic cell development
- Understanding malaria infection dynamics
- Understanding the genetics of neutrophil maturation
- Understanding the neuroimmune regulation of innate immunity
- Understanding the proteins that regulate programmed cell death at the molecular level
- Using cutting-edge single cell tools to understand the origins of cancer
- When healthy cells turn bad: how immune responses can transition to lymphoma
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Lilly Backshell
- Megan Kent
- Naomi Jones
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Wayne Cawthorne
- Wil Lehmann
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- WEHI.TV
Immunology

Immunology is the study of the system that protects our body from infections. Problems with the immune system are linked to many serious health conditions. Our immunology researchers are discovering how the immune system functions in health and disease.
Our immunology research
One-third of our research effort is devoted to immunology. Our researchers are:
- Defining the basic functions of immune cells, how these cells develop, and how they are controlled.
- Revealing what goes wrong in immune disorders including inflammation, autoimmunity, immune deficiency, as well as infectious diseases and cancer.
- Developing new treatments for disease based on immune system modification.
What is immunology?
Immunology is the study of the immune system, which is comprised of specialised cells and molecules. These work together to protect our body from infection by bacteria, viruses, parasites and fungi. The immune system can also prevent the formation of some cancers.
Our immune system can stop most microbes from entering the body, and can stifle their growth and spread. Sometimes, the immune system cannot prevent an infection. Some microbes have developed sophisticated strategies to evade the immune system, allowing them to survive and reproduce within the body.
Adaptive versus innate immunity
Our immune system has diverse strategies to prevent infection. The functions of the immune system can be broadly divided into:
Innate immune system: responds rapidly to microbes, but does not alter significantly on repeat exposure. Important aspects of this are:
- Phagocytosis, or engulfment of microbes by cells.
- Triggering inflammation in response to microbes or tissue damage.
- Releasing substances that limit microbial invasion and recruit immune cells.
Adaptive immune system: develops ‘memory’ to microbes, allowing subsequent immune responses to the same microbe to be faster and larger. This immunological memory can last a lifetime.
Important aspects of adaptive immunity are:
- Cells with receptors that recognise specific microbial proteins.
- Antibodies, which are soluble proteins that can bind a specific microbial protein.
Innate immune responses typically occur more rapidly than adaptive responses. The innate and adaptive immune systems have many interactions, and can involve some of the same cells and molecules.
Immune cells
The immune system involves many different types of cells working together. Many of these are ‘white blood cells’ that develop from blood stem cells in the bone marrow.
Our researchers are contributing to the understanding of how immune cells develop and function. In doing this, they have revealed many sub-types of these cells.
Important immune cells include:
Phagocytes
These are innate immune cells that can engulf (phagocytose) microbes or other particles. They are important in triggering inflammation, and some can alert adaptive immune cells to an infection. Important phagocytes include:
- Dendritic cells
- Neutrophils
- Basophils
- Macrophages
Lymphocytes
These cells include adaptive and innate immune components, with many functions in controlling, stimulating and executing immune responses. Long-lived memory lymphocytes are the source of lifelong immunity to certain infections.
The broad types of lymphocytes are:
- B cells, adaptive immune cells that produce antibodies that specifically bind other proteins, such as on the surface of a microbe.
- T cells, adaptive immune cells that are stimulated by dendritic cells or other phagocytes to become activated against a particular microbe.
- Natural killer cells, which can have innate or adaptive roles in eliminating infections, and also killing cancer cells.
Immune molecules
There are many factors released by immune cells that are important for immune reactions. These include:
- Cytokines, hormone-like signalling proteins that allow cells to communicate with each other via cytokine receptors on the cell surface.
- Antibodies, a type of protein released by B cells. Each antibody can bind a specific protein, called the ‘antigen’, with different antigens recognised by different antibodies. This identifies the antigen as ‘foreign’. The binding of an antibody to a microbe can hamper the microbe’s growth and survival.
Control of the immune response
For good health, both innate and adaptive immune responses need to:
- Start and conclude rapidly to minimise damage to the body’s own cells.
- Only occur in situations of genuine danger, in response to an invading microbe. Immune responses to harmless substances or the body’s own tissues causes disease.
The immune system contains many safeguards that regulate its functions. Many strategies are used to prevent harmful immune responses. This includes systems for destroying or silencing potentially harmful cells that could attack the body’s own tissues.
Immune disorders
Usually the immune system can distinguish our own tissues from invading microbes, and respond appropriately, killing the microbes or infected cells but not harming uninfected or otherwise healthy cells. Defective control of the immune response, leading to misdirected, excessive or inadequate immune responses, underly many immune disorders.
Inflammatory disorders occur when the immune system causes excessive inflammation that damages the body. This may be triggered by an infection, such as in rheumatic fever or occur for no known reason, such as in inflammatory bowel disease.
Autoimmunity is a type of inflammatory disorder that occurs when the immune system mistakenly attacks the body’s own tissues. These disorders are caused by lymphocytes or antibodies reacting to the body’s own tissues.
Significant autoimmune diseases include:
Allergy occurs when the immune system over-reacts to harmless factors in our diet or environment.
Immunodeficiency is a weakened immune system. This causes a person to be infected by microbes more easily than a healthy person.
Cancers of the immune system
Occasionally an immune cell develops changes in its genetic material that allow it to grow uncontrollably, and become long-lived. This can lead to cancers of the immune system, such as:
Immunotherapy
The normal functioning of our immune system is vital to our health. Immune cells can also be harnessed to treat disease, a field called immunotherapy. Examples of immunotherapy include:
- Vaccines expose the immune system to substances that closely resemble a particular microbe, allowing the safe development of adaptive immunity. This protects the body from infection when the microbe is later encountered.
- Targeted therapy can use antibodies to specifically bind to disease-causing molecules or cells. Many targeted therapies for cancer are being developed that bind to specific proteins on the cancer cell’s surface. Another strategy is to target immune cell communication molecules (such as cytokines) to enhance or inhibit the strength of response to cancer or autoimmune diseases.
- Immunosuppression turns off the function of immune cells. Most immunosuppressive medications have widespread effects on immune cells, and can perturb protective as well as harmful immune responses.
- Preventive vaccines switch off a harmful immune response by providing signals to the immune system that a substance is not harmful. Our researchers have developed potential preventive vaccines that are in clinical trials for coeliac disease and type 1 diabetes.
Researchers:
Professor Gabrielle Belz discusses the link between eating green leafy vegetables and digestive health.
Frank Macfarlane Burnet was awarded the Nobel Prize in 1960 and is widely acknowledged as the founder of modern immunology. This animation was created to commemorate the 50th anniversary of Burnet's landmark discovery.
Meet our Eureka Prize winning B cell researchers
Our research into how antibody producing cells become long-lived may provide insights into how certain diseases arise.